Thank focused My will comments be you, in areas. two Ronan.
regulations will products. federal efforts current supplement update both sensible will I And on to second, behind our fair I you the First, update dietary and state on obtain levels. science at our the and
the the In of completed to recently that have update our our past, formulated the cbdMD laid superior are approach everyday on needs two our science studies. products to address to specifically we discussed and I foundation deliver now customers. will clinical for wellness you
The and subjects track preliminary the data findings we the publication. of we're is study, South still and in on clinical customers' and the of share for from Based some to our and CBD Carolina on human customers. data at improve efficacy that key know our broad-spectrum that study core excited messaging really University our to healthy health blend our wellness performed that to does our of areas, assess
reduction from benefits CBD. adults. educating inflammation core serve information pain among Of foundation other of encouraging blend about outcomes the healthy in customer spectrum note, our as indicated improvement, on focus This our results, reduction base mood positive for of and our a broad will
Veterinary owner-oriented activities quality outcomes than to School study benefits Canine typical as clinical That export quality clinical Pain of Inventory Brief as clinical on more Colorado survey, the life. questions and University gate a and from of determine how The hemp our well of interferes or objective pain they extract pain the dogs severity, broad-spectrum and utilizes mobility which life. Medicine, core of analysis series State study as the dog's assess accurately pain at with provided dogs interference data
using impacted [ph] to outcome the measures, accelerometry The a broad our the and scores baseline. objective extract spectrum to perception. caregivers Activity results behavior not the and compared pleased I'm and you for outcome improved. the decreased measures. In increased assessed hemp be dog's words, analysis most as positively of they inform in improvement measures measures trend CPPI spectrum extract both hemp baseline to which when compared of impacted that our data pain objective would broad consumed other client-specific by
improvement some That movement with issues extract. time. consume known cbdMD's have Dogs what when data we hemp show broad-spectrum for supports they
XXXX. publish this in the from data will later We study
support health wellness. guiding can will development The and product everyday data products road our clinical studies map. generated from be our to confirms instrumental customers our It help their
functional better core formulas After that our of campaigns on will our journals, in will We customers. goals. to they our marketing the understand the products help launch the how them on future can matter we achieve areas and their publishing can use guide to data educating to well-respected customers peer-reviewed so data benefits products, most focused
developing cannabinoid customers, which to a sleep, functional to pair areas that formulas ingredients supplements have been our proven field including crowded mood with develop and matter clinically other our most with to that is recovery. approach in proven Our compelling support studied to ingredients clinically dietary
that our executed the spectrum from consumers, studies studies cbdMD's human therapeutics clinical. has flagship broad containing human clinical our also the recent data already new future division. including investigational The of launch informed tinctures was same most in by study's guide studied for softgels, and blend will gummies, products results The
regulatory the both I like our to front, recent would efforts and at on you On state levels. federal update the
to follow the and the challenging a to required FDA's We steps regulatory the agency. regulatory well-established address was our the clarity pathway petition step of citizen in position to to our regulate. required Filing have challenge lack previously refusal discussed
of the year, time January the that path state are for our release for denied basis the We and disagree formally a strongly regulatory new press require used with options. available to they products. the a this and all petition considering at denial same hemp In FDA all
manufacturer and supplements regulations. dietary are federal applicable all supplements of products with any responsible complies hemp-derived Our already
supplement money dietary of $X given very have studies. CBD designed be poorly and for decade million a a farm years after dietary any to former here as XXXX choice to FDA do since the In almost been the been a over drive that, X want recently and CBD squandered the passed. study stated It's on has I not bill hemp forward has clear that that introduced they path was since time, official. FDA And FDA inappropriate supplements. all and as
states which THC step of of concerns supplements. lack Delta further has is This and of forced products our XX, the supplements recent Delta to regulation FDA in, clear to dietary legitimate objective all of specifically of hemp-derived and of which dietary X, derivatives HHC, guidance are none like confuse CHCO address the
customer federal continue levels educate both We supplements and to state and legitimate access been hemp-derived preserved. will have that legislators to to dietary ensure at is the
Florida the a providing in to and company lobbyists craft we public working comments states trade Virginia. active positive and testimony hearings been help and In regulation and and Colorado, groups have as like states, with
and are some are that of hurdles in impact states were still regulatory able be successful in sales efforts hemp-derived to CBD I products with requirements our can sold to there Although the those different markets. products. overcome different that say our
craft market there will our lobbyists robust trade for to continue state amend ensure is with existing policy and to We products. directly regulatory to groups work and a regulations to and
they past the meetings and and have data, policy staffers level, At by our extensive immediately legislators for follow-up we've active for products. citizen path face-to-face phone discussing safety helped and science educate to contacted been we denied We both of where encouraged engagement provide committee with their the Congress a I'm committee with and new speaking hemp directly and years, safety level legislators to FDA stated, the had in and by our who and When our several the recent the simultaneously provided staff. federal studies. been staff petition forward did them toxicology needed them the on legislators and both behind all calls
along to house help has our in instrumental was our has making H.R.XXXfrom to cannabinoid's Notably health efforts, former H.R. We so reintroduced of efforts bipartisan sponsors last and of the dietary with last was the session. it and groups, we This intent in bill a session in the the language chance supplements. XXXX. the regulate trade drive of engaged this that session actively are support shows Congress significant this bill as hemp in further year's the happen, passing with tailor believe
of last Guthrie representative and week, Just the Health [ph] with the moving before and Chair who will We run Larocca, the offices, spent many whereas that we and H.R. H.R. Committee, tasked moving the Committee a Crenshaw, Health XXXX be will [ph] spoke Brett lobbying Pence on. Commerce to XXXX directly time of also undergo We the hill is in Energy Dunkin' colleague myself and significant mark the directly speaking debate members stoppers [ph] up forward. including with
fully feel concerns. He he understood we and our was that engaged,
We dietary Commerce also she been to clarity get Committee, drive on met and hemp books. regulations lead work short much and has to a supplement will with laid, Energy the the continue FDA for expressed be and to desire but There the is help issues the get also we and in stopper sensible engaged. in do groundwork time, more the
related demanding recently staff letter the spoke to the FDA agency questions Oversight as a for a also regulate and Comer, Jamie Congressman staff failure CBD Counsel counsel, Director to to We answers the dietary supplement. with Chief the to who sent
we they oversight articulate will everyone help on and answer upcoming fully to spoke seeking appeared with recent trip, in they the hearing. to be As and asking we're better this lobbying an questions to engaged, understand issues them
oversight, for there is us them involvement us that with of a hope as Comer's willingness gives issues Congress that in be all up their session. get was pursue will and finally request our representative something this done Our office to to they addressed
Carolina interested Lastly and we're specific was to is spend our in Pimasertib topic. and and [ph] certainly time not consumer our and opportunity least, forward. path very North a supplements the on our suggested hearing dietary issues the the He we avid have and to discuss educating with themselves issues able about
on pass dividends inform is that our bio in if that as represents graph the Health all junior similar the we pay Given will of FDA-related Health Senate and [ph] also Committee. the the [indiscernible] Committee, state educate home believe is the member future to legislation introduced and cbdMD through Senate must efforts bill in the
action. our trade Through regulations, dietary our who for NPA willing to take will our committee legislators, a and further pack, and on focused supporting congresspersons for groups supplement hear action the support issues we those sensible take action political
to toxicology daily legislators the science. hemp-derived bring To based other safety supplements, objective and of further leading recommend our dietary safe educate with of efforts both the the use data firm together third-party a and CBD about to to and leading public on safety a are supplement safety working hemp-derived companies we industry
We also to a like-minded the drive other hemp who with CBD. progress path for hold dietary unite highest to supplement are standard themselves companies working on the to strategy supplement
applicable [indiscernible] In dietary with closing, definition dietary But forth supplements our are not products believe compliant set supplement within are are drug all firmly legitimate, we the fully that we derived botanically and regulations. our precluded. products
wellness back pave to other are industry treatment with industry the will for wait while a cannabinoid regulatory to choose the of and clarity internationally. We advocates and for are science-based legal to leaders we fight and we domestically for health way our fair We while approach products. believe continue sit and and the
it like Brad. would I to to turn With back over that,
